# Zanaflex

NDC: 73352-090
Generic name: tizanidine hydrochloride
Labeler / Manufacturer: Trifluent Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250916

FDA application: ANDA213798

## Active ingredients

- TIZANIDINE HYDROCHLORIDE: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73352-090"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73352-090
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9833a1b8-f530-4a06-bc77-7d11b6e94c65